Area of research
Genetics · Cancer Research
Research interest
Research interests include BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, and Nutrition, Genetics, and Disease.
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.
High-Risk Benign Breast Lesions: An Ontario Health (Cancer Care Ontario) Recommendations Report.
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project.
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>.
Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO.
Opportunistic genomic screening has clinical utility: An interventional cohort study.
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study
A systematic review on the management of ductal carcinoma in situ of the breast.
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.
Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action.
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study.
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action
Trends in the Utilization of <i>BRCA1</i> and <i>BRCA2</i> Testing After the Introduction of a Publicly Funded Genetic Testing Program.
Endometriosis in Carriers of a Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>: A Descriptive Analysis of a Large Multicentral <i>BRCA</i> Carrier Cohort.
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results
MRI Surveillance and Breast Cancer Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
Bilateral Oophorectomy and All-Cause Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
Breast Magnetic Resonance Imaging for Preoperative Evaluation of Breast Cancer: A Systematic Review and Meta-Analysis.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
The incidence of pancreatic cancer in women with a <i>BRCA1</i> or <i>BRCA2</i> mutation
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities.